PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 116 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $149,000 | +33.0% | 20,000 | +53.8% | 0.01% | -35.3% |
| Q4 2016 | $112,000 | -73.6% | 13,000 | -80.7% | 0.02% | -85.5% |
| Q3 2016 | $425,000 | +269.6% | 67,200 | +233.6% | 0.12% | +265.6% |
| Q3 2015 | $115,000 | -70.1% | 20,146 | -68.7% | 0.03% | -60.0% |
| Q1 2015 | $385,000 | -3.3% | 64,400 | +22.4% | 0.08% | -39.4% |
| Q4 2014 | $398,000 | – | 52,600 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|